EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diverse Genomic Mechanisms of cfiA Activation in Carbapenem-Resistant Bacteroides fragilis Clinical Isolates from Korea

Yangsoon Lee iD, Hyukmin Lee iD, Yoon Soo Park, Myungsook Kim iD, Kyungwon Lee

Antibiotics · 09.08.2026 · 15 (8) · 763

DOI: 10.3390/antibiotics15080763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.08.2026. Verfasst von Yangsoon Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a National Research Foundation of Korea grant funded by the Korean government (MSIT), National Research Foundation of Korea grant funded by the Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacteroides fragilis is the most clinically important anaerobic bacterium and has shown increasing carbapenem resistance mediated by the cfiA metallo-β-lactamase. Although insertion sequence (IS)-mediated activation of cfiA is a well-recognized mechanism, the contribution of IS-independent genomic mechanisms remains incompletely characterized. This study investigated the phenotypic and genomic mechanisms of cfiA-associated carbapenem resistance in clinical B. fragilis isolates from Korea.

Methods

Twenty-six non-duplicate carbapenem-nonsusceptible B. fragilis isolates were collected from three Korean institutions between 2022 and 2023. Antimicrobial susceptibility was tested by disk diffusion and agar dilution methods, and carbapenemase activity was assessed using the anaerobic carbapenem inactivation method (Ana-CIM) and the meropenem double-ended Etest. Whole-genome sequencing was performed to identify resistance determinants, insertion sequences, promoter structures, and multilocus sequence types.

Results

Among 26 isolates, 12 (46.2%) were cfiA-positive and 14 (53.8%) were cfiA-negative. High-level resistance (imipenem MIC ≥ 32 mg/L; meropenem MIC ≥ 128 mg/L) was observed in four cfiA-positive isolates carrying activating IS elements (IS1187 or IS942) upstream of cfiA. Notably, three additional highly resistant cfiA-positive isolates lacked upstream IS elements and showed distinct genomic features, including tandem duplication of cfiA2 (SEV23_101), duplicated promoter architecture upstream of cfiA14 (SEV23_15), and high-level resistance associated with cfiA18 (SCL22_40). Ana-CIM yielded positive results only among isolates with meropenem MIC ≥ 128 mg/L, whereas the meropenem double-ended Etest failed to discriminate cfiA-associated carbapenemase activity.

Conclusions

These findings indicate that high-level carbapenem resistance in B. fragilis may be associated with several genomic features, including IS-mediated activation, increased cfiA gene dosage, and promoter amplification. Molecular characterization is therefore essential for accurate interpretation of carbapenem resistance in B. fragilis.

Schlagwörter

Stichwörter der Autor:innen

Bacteroides fragiliscarbapenem resistancecfiAinsertion sequencepromoter duplicationwhole-genome sequencing

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.
  • Department of Laboratory Medicine, Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Division of Infectious Disease, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin 16995, Republic of Korea.
  • Infectious Disease Research Center, Seoul Clinical Laboratories, Yongin 16954, Republic of Korea.

ORCID-Profile: Yangsoon Lee, Hyukmin Lee, Myungsook Kim

Förderung

  • a National Research Foundation of Korea grant funded by the Korean government (MSIT)
  • National Research Foundation of Korea grant funded by the Korean government

Zitieren

APA

Lee, Y., Lee, H., Park, Y. S., Kim, M., & Lee, K. (2026). Diverse Genomic Mechanisms of cfiA Activation in Carbapenem-Resistant Bacteroides fragilis Clinical Isolates from Korea. Antibiotics, 15(8), 763. https://doi.org/10.3390/antibiotics15080763

Vancouver

Lee Y, Lee H, Park YS, Kim M, Lee K. Diverse Genomic Mechanisms of cfiA Activation in Carbapenem-Resistant Bacteroides fragilis Clinical Isolates from Korea. Antibiotics. 2026;15(8):763. doi:10.3390/antibiotics15080763

BibTeX
@article{Lee2026,
  author = {Lee, Yangsoon and Lee, Hyukmin and Park, Yoon Soo and Kim, Myungsook and Lee, Kyungwon},
  title = {Diverse Genomic Mechanisms of cfiA Activation in Carbapenem-Resistant Bacteroides fragilis Clinical Isolates from Korea},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {763},
  doi = {10.3390/antibiotics15080763}
}
Kostenlos starten →